The Food and Drug Administration (FDA) on November 22 announced the approval of RxSight Inc’s (Pasadena, California) Light Adjustable Lens and Light Delivery Device.
This is the first system that allows ophthalmologists to make small adjustments to the implanted lens’ power after cataract surgery to improve visual acuity without glasses.
Ophthalmologists can make the adjustments during several postoperative in-office procedures.
FDA approved the RxSight Inc. Light Adjustable Lens and Light Delivery Device, the first medical device system that can make small adjustments to the artificial lens’ power after cataract surgery so that the patient will have better vision when not using glasses.
Source: OR Manager/FDA